retatrutide triple agonist phase 2 obesity trial ⭐️topline results from TRIUMPH-1, a 3 clinical evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon hormone receptor agonist, in adults with or “overweight” BioCentury - Retatrutide data strengthen

Protein intake is key, along with making sure youre getting the right vitamins and nutrients, Dana says

The peptide has an important role in detoxifying reactions such as scavenging cellular hydrogen peroxide and conjugation of electrophilic metabolites of xenobiotics (Franco and Cidlowski, 2012)

Patients can exhibit various neuropsychiatric signs and symptoms: confusion, sleep disruption, cognitive and intellectual dysfunction, impaired motor activity, slowed or slurred speech, and incoordination

In agreement with prior literature [35], this result suggests that GSH is not stable in plasma at 4 o C, and thus samples should not be stored at this temperature

They found that the incidence of certain (not all) serious DR-associated complications was lower in the GLP-1 RA group